Whoop's new blood-testing service, Specialized Panels, offers targeted insights for a one-time fee of $299. This service, powered by Quest Diagnostics, covers 75-89 biomarkers across five panels: heart health, performance, metabolic function, women's health, and men's health. The article explores the significance of this expansion into blood testing for a wearable company known for heart rate variability and sleep tracking. It highlights the targeted nature of the panels, such as the women's health panel, which includes 11 biomarkers to understand perimenopause and hormonal transitions. However, the author emphasizes the potential risks and limitations, including the high cost, the lack of a doctor's review, and the privacy concerns surrounding blood data. The article concludes by raising questions about the line between fitness trackers and medical devices, and the potential implications for user data.
